Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Offersgaard

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|April 6, 2023
Toward a vaccine against hepatitis C virusAnna Offersgaard, Jens Bukh, Judith M Gottwein
Viruses|October 26, 2021
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In VitroYuyong Zhou, Karen A Gammeltoft, Andrea Galli, et al.
Microbiology Spectrum|January 31, 2023
Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like ParticlesAnna Czarnota, Anna Offersgaard, Ania Owsianka, et al.
Vaccines|June 14, 2020
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization EfficiencyAnna Czarnota, Anna Offersgaard, Anne Finne Pihl, et al.
Vaccines|February 26, 2022
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Plos Pathogens|May 13, 2026
Collectin-11, a complement pattern recognition molecule, mediates pulmonary SARS-CoV-2 neutralization and protectionAdrian Sutta, Anna Offersgaard, Carlos Rene Duarte Hernandez, et al.
Scientific Reports|July 17, 2021
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, et al.
Viruses|September 28, 2023
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to NirmatrelvirKaren Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, et al.
Journal of Hepatology|January 6, 2022
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in miceAnne Finne Pihl, Shan Feng, Anna Offersgaard, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 <i>In Vitro</i>Karen A Gammeltoft, Yuyong Zhou, Carlos R Duarte Hernandez, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|April 6, 2023
Toward a vaccine against hepatitis C virusAnna Offersgaard, Jens Bukh, Judith M Gottwein
Viruses|October 26, 2021
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In VitroYuyong Zhou, Karen A Gammeltoft, Andrea Galli, et al.
Microbiology Spectrum|January 31, 2023
Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like ParticlesAnna Czarnota, Anna Offersgaard, Ania Owsianka, et al.
Vaccines|June 14, 2020
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization EfficiencyAnna Czarnota, Anna Offersgaard, Anne Finne Pihl, et al.
Vaccines|February 26, 2022
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density BioreactorAnna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, et al.
Plos Pathogens|May 13, 2026
Collectin-11, a complement pattern recognition molecule, mediates pulmonary SARS-CoV-2 neutralization and protectionAdrian Sutta, Anna Offersgaard, Carlos Rene Duarte Hernandez, et al.
Scientific Reports|July 17, 2021
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, et al.
Viruses|September 28, 2023
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to NirmatrelvirKaren Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, et al.
Journal of Hepatology|January 6, 2022
Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in miceAnne Finne Pihl, Shan Feng, Anna Offersgaard, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 <i>In Vitro</i>Karen A Gammeltoft, Yuyong Zhou, Carlos R Duarte Hernandez, et al.
Pageof 2